Need professional-grade analysis? Visit stockanalysis.com
$20.61B
329.15
4,444
N/A
Bloomage Biotechnology Corp Ltd (688363) trades on SHG in CNY. The company is classified in the Basic Materials sector under the Specialty Chemicals industry. The stock currently trades at CNY42.63, down 1.32% from the previous close.
Over the past year, 688363 has traded between a low of CNY40.59 and a high of CNY60.00. The stock has lost 10.1% over this period. It is currently 28.9% below its 52-week high.
Bloomage Biotechnology Corp Ltd has a market capitalization of $20.61B, with a price-to-earnings ratio of 329.15.
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
Side-by-side comparison against top Basic Materials peers.